3
Announcements
Trials
Browse
Landscape
Status
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
44
Observational
6
Expanded_access
1
Sponsor
Cancer Type
Myeloid
3
Lymphoid
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
9
Pancreatic Neoplasms
5
Sarcoma
4
Prostatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Melanoma
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Uterine Neoplasms
2
Neoplasms
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Sarcoma, Ewing
1
Primary Myelofibrosis
1
PSR Ovarian Cancer With a BRCA Mutation
1
Ovarian Diseases
1
Osteosarcoma
1
Neurofibrosarcoma
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Hodgkin Disease
1
Interventions
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Primary Myelofibrosis
×
Gynecologic
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available